Two large pharmaceutical companies announced a partnership to co-promote an oncology therapy launching within the US market across multiple indications. The organizations had partnered together several years prior on an indication launch, but both had been re-staffed with all new cross-functional teams new to this alliance work. Vynamic was initially contacted by these companies, seeking support in establishing new ways of working for strategic decisions and executional processes, while maximizing efficiencies and dependencies. In addition to supporting those areas, Vynamic ultimately helped navigate an improbable, and highly accelerated launch sequence of two indications receiving approval within two weeks of one another. This unexpected progression of approvals required swift, strategic prioritization to ensure key resources for both companies went live in market, despite compressed timing circumstances.
Product Launch is a fast-paced, often complex time with many moving parts. Navigating across two companies in a co-promote requires hyper-focused coordination across multiple functional areas to ensure processes are defined and communications are clear to avoid delays or other mishaps.
Vynamic deployed launch navigation resources skilled in understanding the nuances and ways of working that would set teams up for success and allow for leadership visibility across both companies, shared tools and processes, and ultimately efficient time to market. Vynamic’s approach focused on these key areas, critical for enabling this coordination:
Launch navigation tools and templates
Cross-company internal process creation & alignment
Cross-company communications & governance
Launch readiness strategy reviews
Cross-functional day 0 executional plans
Promotional asset dashboard
Vynamic created and managed a launch planning approach across two companies, providing the required visibility and alignment across all functional areas, including leadership, and ensured tools were right-sized to meet the needs of all stakeholders. Internal processes related to communication, ways of working, and asset review and approval were designed and implemented and enabled seamless day-of-approval execution across both companies.
The Vynamic team ultimately navigated an improbable launch sequence, receiving approval on the second indication first, and the first indication receiving approval two weeks early. They aggressively accelerated the review and approval of key sales resources, launching less than 2 weeks post approval. Vynamic also coordinated the approval of nearly 30 additional crucial promotional assets across both companies within 15 business days of approval, and 85% of all launch assets were in-market within 30 days post approval.
Additionally, the Vynamic team defined and created an enduring launch plan template, launch milestone tracker, and promotional asset tracker to be leveraged across additional indication launches, providing lasting impact in these key organizations.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Vynamic partnered with a top Life Sciences client for a multi-year omnichannel transformation, enhancing customer experience.
In the Medicare Advantage B2C market, learn how Vynamic streamlined touchpoints and cut costs while enhancing satisfaction
A global gene therapy client partnered with Vynamic to optimize its engagement with treatment centers in preparation for a product launch.